These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19533606)

  • 1. Force control and powder dispersibility of spray dried particles for inhalation.
    Weiler C; Egen M; Trunk M; Langguth P
    J Pharm Sci; 2010 Jan; 99(1):303-16. PubMed ID: 19533606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of solid corrugated particles to enhance powder aerosol performance.
    Chew NY; Chan HK
    Pharm Res; 2001 Nov; 18(11):1570-7. PubMed ID: 11758765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.
    Otake H; Okuda T; Hira D; Kojima H; Shimada Y; Okamoto H
    Pharm Res; 2016 Apr; 33(4):922-31. PubMed ID: 26643921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations.
    Adi H; Traini D; Chan HK; Young PM
    J Pharm Sci; 2008 Jul; 97(7):2780-8. PubMed ID: 17894369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols.
    Chew NY; Chan HK
    Pharm Res; 1999 Jul; 16(7):1098-103. PubMed ID: 10450937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
    Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW
    Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring Bipolar Charge and Mass Distributions of Powder Aerosols by a Novel Tool (BOLAR).
    Wong J; Lin YW; Kwok PC; Niemelä V; Crapper J; Chan HK
    Mol Pharm; 2015 Sep; 12(9):3433-40. PubMed ID: 26222019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How much particle surface corrugation is sufficient to improve aerosol performance of powders?
    Chew NY; Tang P; Chan HK; Raper JA
    Pharm Res; 2005 Jan; 22(1):148-52. PubMed ID: 15771241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques.
    Louey MD; Van Oort M; Hickey AJ
    Pharm Res; 2004 Jul; 21(7):1200-6. PubMed ID: 15290860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro-particle corrugation, adhesion and inhalation aerosol efficiency.
    Adi S; Adi H; Tang P; Traini D; Chan HK; Young PM
    Eur J Pharm Sci; 2008 Sep; 35(1-2):12-8. PubMed ID: 18586091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids.
    Hadinoto K; Phanapavudhikul P; Kewu Z; Tan RB
    Int J Pharm; 2007 Mar; 333(1-2):187-98. PubMed ID: 17084567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of metal salts on aerosol performance of spray dried carrier-free formulations of levofloxacin.
    Barazesh A; Gilani K; Rouini M; Barghi MA
    Daru; 2020 Jun; 28(1):75-85. PubMed ID: 31808069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders.
    Chew NY; Bagster DF; Chan HK
    Int J Pharm; 2000 Sep; 206(1-2):75-83. PubMed ID: 11058812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.